CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
The LIVERATION project aims to evaluate whether additional ablation of tumor margins using radiofrequency can reduce recurrence rates and improve survival for patients with colorectal liver metastases and hepatocellular carcinoma. This multicenter clinical trial will involve 720 patients across 24 centers in six countr…
Colorectal cancer (CRC) ranks fourth in cancer deaths worldwide.
Between 20% and 30% of patients with advanced CRC have liver metastases (CRLM).
Liver cancer ranks second in cancer deaths worldwide, including hepatocellular carcinoma (HCC).
Despite recent advances, liver resection offers the only chance of cure for patients with liver metastases.
However, the recurrence rate of these tumours is high even after post-resection.
The presence of positive margins in the remaining liver after resectio…
CONSORCIO MAR PARC DE SALUT DE BARCELONA
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Spain, MONTCADA I REIXAC
Type: Company (for-profit)
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: No
Portugal, Coimbra
Type: SME
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: Yes
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 sectors.
Guests see up to 5 keywords.
